Literature DB >> 22322947

A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy.

Xinli Zhang1, Chen Chen.   

Abstract

Diabetes mellitus is one of the most common chronic diseases across the world. Cardiovascular complication is the major morbidity and mortality among the diabetic patients. Diabetic cardiomyopathy, a new entity independent of coronary artery disease or hypertension, has been increasingly recognized by clinicians and epidemiologists. Cardiac dysfunction is the major characteristic of diabetic cardiomyopathy. For a better understanding of diabetic cardiomyopathy and necessary treatment strategy, several pathological mechanisms such as impaired calcium handling and increased oxidative stress, have been proposed through clinical and experimental observations. In this review, we will discuss the development of cardiac dysfunction, the mechanisms underlying diabetic cardiomyopathy, diagnostic methods, and treatment options.

Entities:  

Mesh:

Year:  2012        PMID: 22322947     DOI: 10.1007/s12020-012-9623-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  133 in total

Review 1.  Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths.

Authors:  Allan D Struthers; Andrew D Morris
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

2.  Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus.

Authors:  M F Di Carli; D Bianco-Batlles; M E Landa; A Kazmers; H Groehn; O Muzik; G Grunberger
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

3.  Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients.

Authors:  P T Monteagudo; V A Moisés; O Kohlmann; A B Ribeiro; V C Lima; M T Zanella
Journal:  Clin Cardiol       Date:  2000-05       Impact factor: 2.882

4.  Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.

Authors:  Ling Li; Geneviève Renier
Journal:  Metabolism       Date:  2006-11       Impact factor: 8.694

5.  Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway.

Authors:  Jennifer G Duncan; Juliet L Fong; Denis M Medeiros; Brian N Finck; Daniel P Kelly
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

6.  Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart.

Authors:  Darrell D Belke; Eric A Swanson; Wolfgang H Dillmann
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

7.  Redox regulation of Ito remodeling in diabetic rat heart.

Authors:  Xun Li; Zhi Xu; Shumin Li; George J Rozanski
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-11       Impact factor: 4.733

8.  Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.

Authors:  Gang Ye; Naira S Metreveli; Jun Ren; Paul N Epstein
Journal:  Diabetes       Date:  2003-03       Impact factor: 9.461

9.  Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus.

Authors:  John K Boyer; Srihari Thanigaraj; Kenneth B Schechtman; Julio E Pérez
Journal:  Am J Cardiol       Date:  2004-04-01       Impact factor: 2.778

Review 10.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

View more
  24 in total

Review 1.  Implications of ghrelin and hexarelin in diabetes and diabetes-associated heart diseases.

Authors:  Rasha Mofeed Habeeb Mosa; Zhen Zhang; Renfu Shao; Chao Deng; Jiezhong Chen; Chen Chen
Journal:  Endocrine       Date:  2015-02-04       Impact factor: 3.633

Review 2.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

3.  Increased serum levels of ischemia-modified albumin and C-reactive protein in type 1 diabetes patients with ketoacidosis.

Authors:  Shao-gang Ma; Yue Jin; Wei Xu; Wen Hu; Feng Bai; Xiao-juan Wu
Journal:  Endocrine       Date:  2012-03-23       Impact factor: 3.633

Review 4.  Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research.

Authors:  Benjamin M Leon; Thomas M Maddox
Journal:  World J Diabetes       Date:  2015-10-10

Review 5.  Molecular and metabolic mechanisms of cardiac dysfunction in diabetes.

Authors:  Chirag H Mandavia; Annayya R Aroor; Vincent G Demarco; James R Sowers
Journal:  Life Sci       Date:  2012-11-09       Impact factor: 5.037

6.  Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes.

Authors:  A Moura Neto; M C R Parisi; M A Tambascia; E J Pavin; S M Alegre; D E Zantut-Wittmann
Journal:  Endocrine       Date:  2013-04-02       Impact factor: 3.633

7.  Depressed calcium-handling proteins due to endoplasmic reticulum stress and apoptosis in the diabetic heart are attenuated by argirein.

Authors:  F H Shi; Y S Cheng; D Z Dai; H J Peng; X D Cong; Y Dai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-24       Impact factor: 3.000

8.  Of mice and men: modeling cardiovascular complexity in diabetes. Focus on "Mitochondrial inefficiencies and anoxic ATP hydrolysis capacities in diabetic rat heart".

Authors:  Hemal H Patel; Alicia A McDonough
Journal:  Am J Physiol Cell Physiol       Date:  2014-07-16       Impact factor: 4.249

Review 9.  Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.

Authors:  Cecilia C Low Wang; Connie N Hess; William R Hiatt; Allison B Goldfine
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

10.  Non-invasively estimated end-systolic elastance in patients with resistant hypertension and type 2 diabetes mellitus.

Authors:  Trine K Soender; Tine De Backer
Journal:  Heart Vessels       Date:  2013-06-02       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.